5-Bromonicotinic acid can be used as a pharmaceutical intermediate to synthesize 5-aryloyl nicotinic acid compounds. 5-Bromonicotinic acid has the characteristics of good drug similarity, high oral bioavailability, and low toxicity through molecular docking prediction. 5-Bromonicotinic acid has good binding ability with hepatitis virus proteins (binding energy: -4.7 to -5.3 kcal/mol)[1][2].
Molecular Weight:
202.01
Purity:
99.83
CAS Number:
[20826-04-4]
Formula:
C6H4BrNO2
Target:
Drug Intermediate
Application Notes:
MCE Product type: Biochemical Assay Reagents
* VAT and and shipping costs not included. Errors and price changes excepted
